Lack of specificity of antibodies directed against human beta-adrenergic receptors
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The present study was designed to investigate if antibodies against beta-adrenergic receptors (betaARs) can be used to determine expression of betaAR in human myocardium. Western blotting was performed to investigate the specificity of antibodies directed against beta(1)AR and beta(2)AR in human left ventricular tissue. A comparison was made between cardiac tissue from patients with idiopathic dilated cardiomyopathy and ischemic heart disease and nonfailing donors. The antibodies directed against beta(1)AR and beta(2)AR recognized several protein bands at different molecular weights. Moreover, both antibodies also recognized multiple proteins in Chinese hamster ovary cells expressing beta(1)AR, beta(2)AR, and even beta(3)AR. betaAR antibodies are not specific and are not suited to study expression of betaAR in human myocardium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart
SOLARO, R. J., MOIR, A. J. G., & PERRY, S. V. (1976) · Nature · doi:10.1038/262615a0 · Cited by 395 · cited 1×
“Binding of catecholamines to the βadrenergic receptors (βARs) increases contractility of the cardiomyocytes via protein-kinase-A-mediated phosphorylation of downstream target proteins involved in calcium handling (Hasenfuss and Fieske 2002) and myofilament contraction (Solaro et al. 1976).”
Cited by
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
“However, studies with both knock-out mice (Everaerts et al. 2009; Jensen et al. 2009; Jositsch et al. 2009; Lu and Bartfai 2009; Pradidarcheep et al. 2008) or immunoblots comparing staining to cloned receptor subtypes (Bodei etal.2009; Hamdani and van der Velden 2009; Pradidarcheep et al. 2009) demonstrate that this a…”
BackgroundInfluentialThe Glucagon-Like Peptide-1 Receptor—or Not?
Pyke, C., & Knudsen, L. B. (2013) · Endocrinology · doi:10.1210/en.2012-2124 · Cited by 154
Glucagon‐like peptide‐1 receptor expression in the human eye
Hebsgaard, J. B., Pyke, C., Yildirim, E., Knudsen, L. B., Heegaard, S., & Kvist, P. H. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13339 · Cited by 88
“technically difficult and many antibodies have been shown to be unspecific.(4,5) As a result, journals have introduced rigorous reporting requirements for IHC results.”
Background
Metadata
- Authors
- Hamdani, N., & van der Velden, J.
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2009-01-22
- Volume
- 379
- Issue
- 4
- Pages
- 403-407
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2108637054
- Cited by
- 84
- References
- 1
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lack of specificity of antibodies directed against human beta-adrenergic receptors. https://app.cochat.ai/papers/10.1007/s00210-009-0392-1
- The paper
- Hamdani, N., & van der Velden, J. (2009). Lack of specificity of antibodies directed against human beta-adrenergic receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-009-0392-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.